Cargando…
A randomized controlled trial to reduce post-cessation weight gain
BACKGROUND/OBJECTIVES: Weight gain is a barrier to smoking cessation. Previous interventions targeting weight gain while quitting smoking have largely been unsuccessful. The current study aimed to assess the efficacy of weight stability and weight loss interventions compared to a low-intensity, self...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958320/ https://www.ncbi.nlm.nih.gov/pubmed/36841886 http://dx.doi.org/10.1038/s41366-023-01286-5 |
_version_ | 1784894996774649856 |
---|---|
author | Pebley, Kinsey Bursac, Zoran Klesges, Robert C. Ebbert, Jon O. Womack, Catherine R. Graber, Julia Little, Melissa A. Derefinko, Karen J. Krukowski, Rebecca A. |
author_facet | Pebley, Kinsey Bursac, Zoran Klesges, Robert C. Ebbert, Jon O. Womack, Catherine R. Graber, Julia Little, Melissa A. Derefinko, Karen J. Krukowski, Rebecca A. |
author_sort | Pebley, Kinsey |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: Weight gain is a barrier to smoking cessation. Previous interventions targeting weight gain while quitting smoking have largely been unsuccessful. The current study aimed to assess the efficacy of weight stability and weight loss interventions compared to a low-intensity, self-guided bibliotherapy weight management group. SUBJECTS/METHODS: A randomized controlled trial with 12-month follow-up from 2018 to 2022 was conducted with participants (N = 305) who reported smoking at least five cigarettes per day for the last year and interest in quitting initially recruited from the Memphis, TN, USA area. Recruitment was expanded nationally with the onset of the COVID-19 pandemic. Subsequently, 276 completed 12-month follow-up. INTERVENTIONS/METHODS: The Bibliotherapy group was provided a weight management book. Both the Stability and Loss groups met via telephone for eight weeks to learn strategies for maintaining/losing weight, respectively. All three groups then received the same six-week smoking cessation intervention, with six months of varenicline provided. RESULTS: Individuals in the Loss group lost more weight (−2.01 kg, SE = 1.58) than individuals in the Bibliotherapy group (+1.08 kg, SE = 1.49, p = 0.0004), while the Stability group (−0.30 kg, SE = 1.56) was not significantly different from the Bibliotherapy group (p = 0.17). Those in the Stability group did not gain a significant amount of weight. Participants in the Loss group did not gain back all weight lost after smoking cessation and ended the study approximately 2.01 kg lower than baseline. The Bibliotherapy group did not gain the amount of weight expected after cessation. There were no significant differences between groups related to self-reported smoking cessation at each time point except at eight-month follow-up (p = 0.005). CONCLUSIONS AND RELEVANCE: Results indicated the Stability and the Loss interventions were effective for preventing post-smoking cessation weight gain, with the Loss group having the benefit of sustained weight loss. These interventions may be helpful to implement to combat weight gain and potentially facilitate smoking cessation. TRIAL REGISTRATION: The trial is registered on clinicaltrials.gov (NCT03156660). [Image: see text] |
format | Online Article Text |
id | pubmed-9958320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99583202023-02-28 A randomized controlled trial to reduce post-cessation weight gain Pebley, Kinsey Bursac, Zoran Klesges, Robert C. Ebbert, Jon O. Womack, Catherine R. Graber, Julia Little, Melissa A. Derefinko, Karen J. Krukowski, Rebecca A. Int J Obes (Lond) Article BACKGROUND/OBJECTIVES: Weight gain is a barrier to smoking cessation. Previous interventions targeting weight gain while quitting smoking have largely been unsuccessful. The current study aimed to assess the efficacy of weight stability and weight loss interventions compared to a low-intensity, self-guided bibliotherapy weight management group. SUBJECTS/METHODS: A randomized controlled trial with 12-month follow-up from 2018 to 2022 was conducted with participants (N = 305) who reported smoking at least five cigarettes per day for the last year and interest in quitting initially recruited from the Memphis, TN, USA area. Recruitment was expanded nationally with the onset of the COVID-19 pandemic. Subsequently, 276 completed 12-month follow-up. INTERVENTIONS/METHODS: The Bibliotherapy group was provided a weight management book. Both the Stability and Loss groups met via telephone for eight weeks to learn strategies for maintaining/losing weight, respectively. All three groups then received the same six-week smoking cessation intervention, with six months of varenicline provided. RESULTS: Individuals in the Loss group lost more weight (−2.01 kg, SE = 1.58) than individuals in the Bibliotherapy group (+1.08 kg, SE = 1.49, p = 0.0004), while the Stability group (−0.30 kg, SE = 1.56) was not significantly different from the Bibliotherapy group (p = 0.17). Those in the Stability group did not gain a significant amount of weight. Participants in the Loss group did not gain back all weight lost after smoking cessation and ended the study approximately 2.01 kg lower than baseline. The Bibliotherapy group did not gain the amount of weight expected after cessation. There were no significant differences between groups related to self-reported smoking cessation at each time point except at eight-month follow-up (p = 0.005). CONCLUSIONS AND RELEVANCE: Results indicated the Stability and the Loss interventions were effective for preventing post-smoking cessation weight gain, with the Loss group having the benefit of sustained weight loss. These interventions may be helpful to implement to combat weight gain and potentially facilitate smoking cessation. TRIAL REGISTRATION: The trial is registered on clinicaltrials.gov (NCT03156660). [Image: see text] Nature Publishing Group UK 2023-02-25 2023 /pmc/articles/PMC9958320/ /pubmed/36841886 http://dx.doi.org/10.1038/s41366-023-01286-5 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Pebley, Kinsey Bursac, Zoran Klesges, Robert C. Ebbert, Jon O. Womack, Catherine R. Graber, Julia Little, Melissa A. Derefinko, Karen J. Krukowski, Rebecca A. A randomized controlled trial to reduce post-cessation weight gain |
title | A randomized controlled trial to reduce post-cessation weight gain |
title_full | A randomized controlled trial to reduce post-cessation weight gain |
title_fullStr | A randomized controlled trial to reduce post-cessation weight gain |
title_full_unstemmed | A randomized controlled trial to reduce post-cessation weight gain |
title_short | A randomized controlled trial to reduce post-cessation weight gain |
title_sort | randomized controlled trial to reduce post-cessation weight gain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958320/ https://www.ncbi.nlm.nih.gov/pubmed/36841886 http://dx.doi.org/10.1038/s41366-023-01286-5 |
work_keys_str_mv | AT pebleykinsey arandomizedcontrolledtrialtoreducepostcessationweightgain AT bursaczoran arandomizedcontrolledtrialtoreducepostcessationweightgain AT klesgesrobertc arandomizedcontrolledtrialtoreducepostcessationweightgain AT ebbertjono arandomizedcontrolledtrialtoreducepostcessationweightgain AT womackcatheriner arandomizedcontrolledtrialtoreducepostcessationweightgain AT graberjulia arandomizedcontrolledtrialtoreducepostcessationweightgain AT littlemelissaa arandomizedcontrolledtrialtoreducepostcessationweightgain AT derefinkokarenj arandomizedcontrolledtrialtoreducepostcessationweightgain AT krukowskirebeccaa arandomizedcontrolledtrialtoreducepostcessationweightgain AT pebleykinsey randomizedcontrolledtrialtoreducepostcessationweightgain AT bursaczoran randomizedcontrolledtrialtoreducepostcessationweightgain AT klesgesrobertc randomizedcontrolledtrialtoreducepostcessationweightgain AT ebbertjono randomizedcontrolledtrialtoreducepostcessationweightgain AT womackcatheriner randomizedcontrolledtrialtoreducepostcessationweightgain AT graberjulia randomizedcontrolledtrialtoreducepostcessationweightgain AT littlemelissaa randomizedcontrolledtrialtoreducepostcessationweightgain AT derefinkokarenj randomizedcontrolledtrialtoreducepostcessationweightgain AT krukowskirebeccaa randomizedcontrolledtrialtoreducepostcessationweightgain |